Cargando…
Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467518/ https://www.ncbi.nlm.nih.gov/pubmed/36108660 http://dx.doi.org/10.1016/S2213-2600(22)00365-4 |
| _version_ | 1784788210023399424 |
|---|---|
| author | Kalil, Andre C Proschan, Michael |
| author_facet | Kalil, Andre C Proschan, Michael |
| author_sort | Kalil, Andre C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9467518 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94675182022-09-13 Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? Kalil, Andre C Proschan, Michael Lancet Respir Med Comment Elsevier Ltd. 2022-12 2022-09-12 /pmc/articles/PMC9467518/ /pubmed/36108660 http://dx.doi.org/10.1016/S2213-2600(22)00365-4 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Kalil, Andre C Proschan, Michael Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? |
| title | Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? |
| title_full | Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? |
| title_fullStr | Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? |
| title_full_unstemmed | Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? |
| title_short | Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? |
| title_sort | complement c5a inhibition: a new form of covid-19 treatment for mechanically ventilated patients? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467518/ https://www.ncbi.nlm.nih.gov/pubmed/36108660 http://dx.doi.org/10.1016/S2213-2600(22)00365-4 |
| work_keys_str_mv | AT kalilandrec complementc5ainhibitionanewformofcovid19treatmentformechanicallyventilatedpatients AT proschanmichael complementc5ainhibitionanewformofcovid19treatmentformechanicallyventilatedpatients |